Kathryn R. Wagner
Department of Neurology
The Johns Hopkins University School of Medicine
Baltimore
MD 21205
USA
Name/email consistency: high
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Wagner, K.R., Fleckenstein, J.L., Amato, A.A., Barohn, R.J., Bushby, K., Escolar, D.M., Flanigan, K.M., Pestronk, A., Tawil, R., Wolfe, G.I., Eagle, M., Florence, J.M., King, W.M., Pandya, S., Straub, V., Juneau, P., Meyers, K., Csimma, C., Araujo, T., Allen, R., Parsons, S.A., Wozney, J.M., Lavallie, E.R., Mendell, J.R. Ann. Neurol. (2008)
- Approaching a new age in Duchenne muscular dystrophy treatment. Wagner, K.R. Neurotherapeutics : J. American Society Experimental Neurotherapeutics (2008)
- Current treatment of adult Duchenne muscular dystrophy. Wagner, K.R., Lechtzin, N., Judge, D.P. Biochim. Biophys. Acta (2007)
- Muscle regeneration in the prolonged absence of myostatin. Wagner, K.R., Liu, X., Chang, X., Allen, R.E. Proc. Natl. Acad. Sci. U.S.A. (2005)
- Muscle regeneration through myostatin inhibition. Wagner, K.R. Curr. Opin. Rheumatol (2005)
- Genetic diseases of muscle. Wagner, K.R. Neurol. Clin (2002)